| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |